Epidemiology, Clinical Characteristics, and Outcomes for Heart Failure with Improved Ejection Fraction by Chronological Age

Heart Failure

Type 2 diabetes and chronic kidney disease combinations in heart failure across the ejection fraction spectrum: clinical associations, medication use, and cause-specific outcomes: a contemporary, real-world analysis of the Swedish Heart Failure Registry

Eur J Heart Fail

Ferrannini G, Pol T, Ljungman C, Dahlström U, Merolla A, Lund LH

doi: 10.1093/ejhf/xuag249

Heart Failure

Incidence, medical therapy, and outcomes in heart failure with improved ejection fraction across guideline definitions

Am Heart J

Agharahmanian A, Min KH, Go AS, Parikh RV, Ambrosy AP, Tan TC, Svetlichnaya J, Vardeny O, Solomon SD, Inciardi RM, Vaduganathan M, Sandhu AT, Ku IA, Bhatt AS

doi: 10.1016/j.ahj.2026.107595

Heart Failure

Heart Failure With Preserved Ejection Fraction Across the Spectrum of Body Mass Index: Hemodynamic and Echocardiographic Characteristics and Outcomes

JACC Heart Fail

Harrington J, Giczewska A, Rao VN, Fudim M, Peters AE, Chrischilles E, Jones WS, May H, Steinberg BA, VanWormer J, Cyr DD, Felker GM

doi: 10.1016/j.jchf.2025.102768

Heart Failure

Modeling Individual Patient Outcomes After Interatrial Shunt Treatment in Heart Failure With Reduced and Preserved Ejection Fraction: The RELIEVE-HF Trial

Circ Heart Fail

Stone GW, Lindenfeld J, Zile MR, Anker SD, Rodés-Cabau J, Snyder C, Kar S, Pfeiffer MP, Bayes-Genis A, Bax JJ, Bank AJ, Núñez J, Lee EC, Laufer-Perl M, Moravsky G, Litwin SE, Holcomb R, Eigler NL, Abraham WT, RELIEVE-HF Investigators

doi: 10.1161/CIRCHEARTFAILURE.125.014100

Heart Failure

Effects of semaglutide in obesity-related heart failure with preserved ejection fraction across the age spectrum: Findings from the STEP-HFpEF programme

Eur J Heart Fail

Pandey A, Moroney M, Verma S, Borlaug BA, Butler J, Davies MJ, Kitzman DW, Shah SJ, Petrie MC, Rönnbäck C, Domdey A, Rasmussen S, Chinnakondepalli KM, Patel S, Kosiborod MN

doi: 10.1002/ejhf.70049

Heart Failure

Characteristics and outcomes of patients with heart failure and history of malignancy: Data from Swedish Heart Failure Registry and the National Cancer Register

Eur J Heart Fail

Ameri P, Costa P, Benson L, Stolfo D, Sayour NV, Ljungman C, Butler J, Anker SD, Girerd N, Keramida K, Filippatos G, Lund LH, Lindberg F, Savarese G

doi: 10.1002/ejhf.3775

Heart Failure

Blood pressure, safety and clinical efficacy of vericiguat in chronic heart failure with reduced ejection fraction: Insights from the VICTOR trial

Eur J Heart Fail

Mentz RJ, Butler J, McMullan CJ, Wojdyla DM, Anstrom KJ, Barash I, Bonaca MP, Borentain M, Corda S, Ezekowitz JA, Gates D, Lam CSP, Lewis EF, Lindenfeld J, O'Connor CM, Ponikowski P, Reddy YNV, Rosano GMC, Saldarriaga C, Senni M, Teixeira PP, Udelson J, Urbinati A, Vlajnic V, Voors AA, Xing A, Zannad F, VICTOR Study Group

doi: 10.1002/ejhf.70033

Heart Failure

One-Year Outcomes in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction Prescribed Quadruple Medical Therapy at Discharge

JAMA Cardiol

Greene SJ, Xu H, Chiswell K, Felker GM, Lewsey SC, Divanji PH, Goertz HP, Heitner SB, Shreay S, Pandey A, Yancy CW, Butler J, Fonarow GC

doi: 10.1001/jamacardio.2025.5339

Heart FailureTherapy and Intervention

Clinical Application of Guideline-Directed Medical Therapy in TAVR Patients With Heart Failure and Reduced Ejection Fraction

JACC Cardiovasc Interv

Kobari Y, Maznyczka A, Khokhar AA, Sørensen LM, Lulic D, Bieliauskas G, Raja AA, Ersbøll MK, Rossing K, Gustafsson F, Køber L, Prendergast B, Fosbøl E, De Backer O

doi: 10.1016/j.jcin.2025.10.050

Related content

Type 2 diabetes and chronic kidney disease combinations in heart failure across the ejection fraction spectrum: clinical associations, medication use, and cause-specific outcomes: a contemporary, real-world analysis of the Swedish Heart Failure Registry

Incidence, medical therapy, and outcomes in heart failure with improved ejection fraction across guideline definitions

Heart Failure With Preserved Ejection Fraction Across the Spectrum of Body Mass Index: Hemodynamic and Echocardiographic Characteristics and Outcomes

Modeling Individual Patient Outcomes After Interatrial Shunt Treatment in Heart Failure With Reduced and Preserved Ejection Fraction: The RELIEVE-HF Trial

Effects of semaglutide in obesity-related heart failure with preserved ejection fraction across the age spectrum: Findings from the STEP-HFpEF programme

Characteristics and outcomes of patients with heart failure and history of malignancy: Data from Swedish Heart Failure Registry and the National Cancer Register

Blood pressure, safety and clinical efficacy of vericiguat in chronic heart failure with reduced ejection fraction: Insights from the VICTOR trial

One-Year Outcomes in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction Prescribed Quadruple Medical Therapy at Discharge

Clinical Application of Guideline-Directed Medical Therapy in TAVR Patients With Heart Failure and Reduced Ejection Fraction